Everyday Health on MSN
Hereditary angioedema (HAE): When and how to use on-demand (acute) medications
Learn how to manage hereditary angioedema (HAE) attacks with on-demand medications, from identifying early symptoms to ...
Angioedema is the rapid edema, or swelling, of the area beneath the skin or mucosa. It is normally caused by an allergic reaction, but it may also be hereditary. Angioedema affects approximately 10-20 ...
RESEARCH TRIANGLE PARK, N.C., May 13, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present new real-world evidence at the 2026 ...
Angioedema, a type of swelling that affects the skin and tissues of the body, commonly affects the lips. Angioedema is a type of swelling that affects the deep tissues of the skin and other systems.
Everyday Health on MSN
How to Travel With Hereditary Angioedema (HAE): Essential Tips for a Safe and Stress-Free Journey
Learn essential tips for stress-free travel with HAE, including medication management, packing advice, nutrition, and ...
Angioedema is deep tissue swelling that may occur due to various health conditions. Treating angioedema swelling depends on the cause. Angioedema may be acute or chronic, and acute symptoms may last ...
Angioedema is a well-known side effect of treatment with an angiotensin-converting enzyme (ACE) inhibitor and one that we have been willing to accept in view of the incidence of the problem and the ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
New York, USA, May 06, 2025 (GLOBE NEWSWIRE) -- Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses ...
MedPage Today on MSN
Hereditary Angioedema Prophylaxis: Persistence and Adherence
Data show many patients discontinue or switch treatment within the first year ...
Topline data from CHAPTER-3, a pivotal Phase 3 study of deucrictibant XR for the prophylaxis of HAE attacks, expected in 3Q2026Timeline for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results